Baratan Tablets 80 mg (Valsartan)

Adult dose

Essential Hypertension: It is recommended to administer 80 mg orally once daily as valsartan. If blood pressure control is inadequate, the dose may be increased to 160 mg per day, and a maximum of 320 mg may be reached. Elderly patients (75 years and older): Start with 40 mg orally once daily. Patients with kidney impairment: For those with a creatinine clearance of 10 to 20 mL/min, start with 40 mg orally once daily. If the clearance is less than 10 mL/min, this drug should not be administered.

Child dose

Safety and efficacy have not been established in children and adolescents under 18 years, so it should not be administered.

This drug can cause severe harm to the fetus if taken during pregnancy, particularly in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Women who are pregnant or may become pregnant, as well as breastfeeding women, should not use this medication. It is not safe to administer this drug to patients with severely impaired liver function, severe kidney diseases, and certain hereditary angioedema patients. Special caution is required when using this drug in elderly patients, in patients with hyperkalemia, and in those with slightly impaired liver function; dosage should be adjusted as necessary. Blood pressure may drop rapidly, so patients' conditions should be carefully monitored when starting the medication or increasing the dose. Caution is needed when used in conjunction with other antihypertensive medications or potassium-sparing diuretics, as it may dangerously elevate potassium levels in the blood. This drug can cause dizziness or drowsiness; caution is necessary when driving or operating machinery. It is important to regularly check kidney function and blood electrolytes during treatment with this drug to ensure no abnormalities arise. In the event of an overdose, symptoms such as low blood pressure and decreased consciousness may occur, so immediate medical attention should be sought for appropriate treatment. Safety and efficacy have not been established in children and adolescents under 18 years, and it is advisable not to use this medication for them. This drug should be stored out of reach of children and not transferred to other containers as it helps maintain quality.

Serious side effects

Hives, severe swelling (including angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, oral/ocular mucosal pain, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme fatigue, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, visual disturbances

Mild side effects

• Headache
• dizziness
• viral infections
• upper respiratory tract infections
• cough
• diarrhea
• fatigue
• rhinitis
• sinusitis
• back pain

This drug should be stored in a tightly sealed container to prevent exposure to air and moisture, and it is advisable to keep it in a cool place at a temperature below 30 degrees Celsius.

Appearance

Pink round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle